Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) EBT Margin (2020 - 2025)

Historic EBT Margin for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to 146.68%.

  • Rapid Micro Biosystems' EBT Margin rose 20500.0% to 146.68% in Q3 2025 from the same period last year, while for Sep 2025 it was 145.05%, marking a year-over-year increase of 397200.0%. This contributed to the annual value of 167.08% for FY2024, which is 657700.0% up from last year.
  • According to the latest figures from Q3 2025, Rapid Micro Biosystems' EBT Margin is 146.68%, which was up 20500.0% from 163.14% recorded in Q2 2025.
  • Over the past 5 years, Rapid Micro Biosystems' EBT Margin peaked at 117.73% during Q4 2024, and registered a low of 442.08% during Q1 2021.
  • Moreover, its 5-year median value for EBT Margin was 237.37% (2024), whereas its average is 253.67%.
  • Its EBT Margin has fluctuated over the past 5 years, first crashed by -2009400bps in 2021, then surged by 1996900bps in 2023.
  • Quarter analysis of 5 years shows Rapid Micro Biosystems' EBT Margin stood at 279.78% in 2021, then tumbled by -34bps to 375.86% in 2022, then soared by 53bps to 176.17% in 2023, then soared by 33bps to 117.73% in 2024, then decreased by -25bps to 146.68% in 2025.
  • Its EBT Margin was 146.68% in Q3 2025, compared to 163.14% in Q2 2025 and 156.22% in Q1 2025.